Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs.

With more...


Article type

Editorial


Article page

97-99


Authors Details

Aseem Setia, Sankha Bhattacharya*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 410

PDF Downloaded: 271


Mucormycosis and its implication in COVID-19


Editorial

Author Details : Aseem Setia, Sankha Bhattacharya*

Volume : 8, Issue : 2, Year : 2021

Article Page : 97-99

https://doi.org/10.18231/j.ijpp.2021.016



Suggest article by email


Abstract

Mucormycosis is a life-threatening fungal infection caused by a group of moulds known as mucormycetes.
It is a viral disease, increasingly progressive, rapidly triggers in diabetic, immunocompromised and trauma
patients. Diabetic patients seem to have the classic rhinocerebral variant. Rhinocerebral mucormycosis
begins as a nasal cavity, paranasal sinus, and orbital soft tissue infection. In immunocompetent patients,
direct injection also induces cutaneous form. Cutaneous mucormycosis occurs in soft tissue and may infect
underlying tissues. Mucormycosis is more frequent in people with major underlying disorders such as
diabetic acidosis or acute leukaemia and those taking corticosteroids or cytotoxic drugs. This disease
occurs in patients by inhaling fungus spores. Mucormycosis occurs in clinical manifestations. Disseminated
mucormycosis is a rare form of mucormycosis, affecting individuals with compromised immune systems.
The disease travels to other areas of the body, thereby being prevalent. Brain, core, spleen, eyes, and other
organs are among the organs that may be affected. Mucormycosis is a dangerous infection that requires
antifungal drugs such as amphotericin B, posaconazole, or isavuconazole. This compilation addresses
conceptual background on medicines used to treat mucormycosis, especially in India.

Keywords: Mucormycosis, Amphotericin B, Diabetic acidosis, COVID-19.


How to cite : Setia A , Bhattacharya S , Mucormycosis and its implication in COVID-19. Indian J Pharm Pharmacol 2021;8(2):97-99

Copyright © 2021 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (creativecommons.org)







Wiki in hindi